Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  eltrombopag olamine
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-18 of 18 for your search:
Start Over
A Rollover Study to Provide Continued Treatment With Eltrombopag
Phase: Phase IV
Type: Natural history/Epidemiology
Status: Active
Age: 1 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 200170, NCT01957176
A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS)
Phase: Phase III
Type: Biomarker/Laboratory analysis, Health services research, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 112121, NCT02158936
Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia
Phase: Phase II, Phase I
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: MCC-16523, NCT01286038
Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 65
Sponsor: Pharmaceutical / Industry
Protocol IDs: PrE0901, ELT114465, NCT01656252
A Study of Eltrombopag in Patients With CMML and Thrombocytopenia
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: GFM-LMMC-Eltrombopag, 2013-001779-19, NCT02323178
A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS)
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: NHLBI
Protocol IDs: 090199, 09-H-0199, NCT00961064
Eltrombopag for Management of Thrombocytopenia
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2011-0319, NCI-2011-03336, NCT01428635
Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: VI-Plt-01, NCT01610180
Eltrombopag for Enhancing Platelet Engraftment in Adult Patients Undergoing Cord Blood Transplantation
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 7114, NCT01757145
Lenalidomide and Eltrombopag Olamine in Treating Patients With Symptomatic Anemia in Low or Intermediate Myelodysplastic Syndrome
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2012-407, NCI-2013-01219, 12-007, RV--MDS-PI-0645, 115479, P30CA013330, NCT01772420
A Safety and Efficacy Study of Eltrombopag in Subjects With AML
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 117146, NCT01890746
Extended Dosing With Eltrombopag for Severe Aplastic Anemia
Phase: Phase II
Type: Treatment
Status: Active
Age: 2 and over
Sponsor: NHLBI
Protocol IDs: 130133, 13-H-0133, NCT01891994
Eltrombopag With or Without Hypomethylating Agent After Hypomethylating Agent Failure For Patients With Myelodysplastic Syndrome (MDS)
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2013-0225, NCI-2013-02252, NCT01893372
Eltrombopag With Decitabine in Advanced Myelodysplastic Syndrome (MDS)
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2013-0590, NCI-2014-00856, NCT02010645
Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy
Phase: Phase II
Type: Supportive care
Status: Active
Age: 60 and over
Sponsor: NCI, Other
Protocol IDs: CASE4913, NCI-2014-00252, P30CA043703, NCT02071901
A Randomized Placebo-controlled Phase 2 Study of Decitabine With or Without Eltrombopag in AML Patients
Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 65 and over
Sponsor: Other
Protocol IDs: TUD-DELTA1-063, 2014-003150-13, NCT02446145
Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia
Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: I 206111, NCI-2012-00215, NCT01550185
Start Over